Safety Outcomes and Infectious Complications Following Yttrium-90 Radioembolization in Patients with Prior Biliary Interventions: A Comprehensive Review
Year: 2026
Type: article
Study design: Systematic Review
Abstract: Background: Yttrium-90 radioembolization (Y-90) is an established locoregional therapy for primary and metastatic liver malignancies. Patients with prior biliary intervention may face a higher risk of infectious complications because of altered biliary anatomy and bacterial colonization. Objective: To evaluate the incidence of infectious complications after Y-90 radioembolization in patients with prior biliary intervention. Methods: PubMed, Embase, and Scopus were searched from inception to June 2026, and risk of bias was assessed for each study. Studies were synthesized descriptively, with per-study proportions and crude totals that count overlapping patients once. Results: Eight studies were included: six retrospective cohorts and two case reports. Four cohorts reported per-patient outcomes in 152 patients; one reported only per procedure, and another was a subset of a larger cohort. Hepatobiliary infection (liver abscess or cholangitis) occurred in 12 of 152 patients (7.9%), liver abscess in 10 (6.6%), cholangitis in 5 (3.3%), and sepsis with hepatobiliary infection in 8 (5.3%); 2 patients died of infection (1.3%). Conclusion: Hepatobiliary infection after Y-90 radioembolization in patients with prior biliary intervention appears less frequent than reported after chemoembolization but more frequent than with intact biliary anatomy. Radioembolization may be a reasonable option in this population.
Source: Current Oncology
Institutions: Johns Hopkins University, Johns Hopkins Medicine, The University of Texas Health Science Center at Houston, Columbia University Irving Medical Center, Harvard University, Massachusetts General Hospital, Ochsner Health System, Ochsner Medical Center, University of California San Diego, University of Arizona, University of Alabama at Birmingham, Icahn School of Medicine at Mount Sinai, University of North Carolina at Chapel Hill
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,654
OpenAlex ID: W7236835173
